IONS Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases.

$52.88  -2.42 (-4.38%)
As of 03/03/2021 15:59:24 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
USA
USA
02/21/2001
139,823,135
900,028
$7,732,219,366
0.00%
SEC Edgar Online
10-Q
10-K
462222100
US4622221004
BDJ0LS6

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-17.13
9.20
10.60
-53.51%
-61.88%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy